论文部分内容阅读
本组用乙型肝炎表面抗原(HSsAg)特异性免疫核糖核酸(iRNA)治疗慢性肝炎21例。按1978年全国病毒性肝炎会议制订的“病毒性肝炎防治方案”规定的诊断标准,计慢性迁延型(慢迂肝)9例,慢性活动型(慢活肝)12例,均为住院病人。用 HBsAg特异性 iRNA 治疗前病程均在半年以上,其中19例在1年以上;HBsAg 持续阳性3个月以上,多数持续阳性1年以上,住院后经2月～4年的其他多种治疗无效者。所用 HBsAg 特异性 iRNA 系由我院免疫室供应。全部为单一治疗,首次用 HBsAg 特异性 iRNA 前先用10%斑蟊酒精纸片于前臂内侧发
This group with hepatitis B surface antigen (HSSAg) specific immunological ribonucleic acid (iRNA) treatment of chronic hepatitis in 21 cases. According to the diagnostic criteria of “viral hepatitis prevention and cure plan” formulated by the National Conference on Viral Hepatitis in 1978, 9 cases were chronic degenerative type (chronic cirrhosis) and 12 cases were chronic active type (slow living liver), all of whom were hospitalized patient. HBsAg-specific iRNA treatment before the course of more than six months, of which 19 cases in more than 1 year; HBsAg continued positive for more than 3 months, the majority of persistent positive for more than 1 year, after hospitalization after 2 to 4 years of other multiple invalidity By. HBsAg-specific iRNA used by the Department of immunization room supply. All are monotherapies, first with HBsAg-specific iRNA pre-treated with 10% cantharidin alcohol in the forearm